Back    Zoom +    Zoom -
<IPO>MINDRAY BIO-MEDICAL Submits Application for HK Listing
Recommend
5
Positive
5
Negative
1
MINDRAY BIO-MEDICAL (300760.SZ), a leading medical device company in China, submitted a listing application to the Stock Exchange, with Huatai International and JPMorgan being its joint sponsors.

Data from market research institutions indicate that MINDRAY BIO-MEDICAL's market value scale in China's medical device industry in 2024 has surpassed the total of the second to fifth leaders in the sector, according to preliminary prospectus information.

Related NewsCICC: A-shr Valuation Remains in Reasonable Range; Significance of Fundamentals Rising; Focus on 3 Themes
Over the past decade, the Company's revenue compound growth rate reached approx. 18%, with net profit surging over 10x. Its products and solutions cover various fields including in vitro diagnostics, life information & support, medical imaging and minimally invasive surgery, etc..
AASTOCKS Financial News
Website: www.aastocks.com